Novitium Pharma Drug Patent Portfolio
Novitium Pharma owns 2 orange book drugs protected by 2 US patents Given below is the list of Novitium Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878022 | Hydrochlorothiazide compositions | 23 Jan, 2044 | Active |
| US11224572 | Stable oral liquid composition of terazosin | 18 Jan, 2042 | Active |
Novitium Pharma's Family Patents
Novitium Pharma Drug List
Given below is the complete list of Novitium Pharma's drugs and the patents protecting them.
1. Inzirqo
Inzirqo is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11878022 | Hydrochlorothiazide compositions |
23 Jan, 2044
(18 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inzirqo's drug page
2. Tezruly
Tezruly is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11224572 | Stable oral liquid composition of terazosin |
18 Jan, 2042
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tezruly's drug page